HPGC Renmintongtai Pharmaceutical Corp. A | Ownership
Companies that own HPGC Renmintongtai Pharmaceutical Corp. A
Hwabao Trust Co., Ltd. (Investment Portfolio)
4,529,412
0.78%
2,878,949
0.34%
09/30/2017
Lion Fund Management Co., Ltd.
3,800,017
0.66%
-3,390,304
0.2%
09/30/2017
Chang'An International Trust Co. Ltd.
3,664,100
0.63%
3,664,100
0.28%
09/30/2017
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
2,470,834
0.43%
260,860
0.07%
09/30/2017
The Vanguard Group, Inc.
798,534
0.14%
0
0%
07/31/2018
China International Fund Management Co., Ltd.
576,800
0.1%
125,356
0.02%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
500,000
0.09%
-6,300,000
0.01%
12/31/2017
Bosera Asset Management Co., Ltd.
115,400
0.02%
115,400
0%
12/31/2017
Truvalue Asset Management Co. Ltd.
82,300
0.01%
82,300
0.01%
12/31/2017
Rongtong Fund Management Co., Ltd.
47,441
0.01%
-47,500
0%
12/31/2017
| Address |
418 Hayao Road
Harbin Heilongjiang 150071
China
|
|
Employees
|
- |
| Website |
http://www.hyrmtt.com.cn |
| Updated |
07/08/2019 |
| HPGC Renmintongtai Pharmaceutical Corp. engages in the wholesale and retail of pharmaceutical products. It operates through the following business segments: Drug retail, Commercial wholesale, Logistics, E-commerce, Specialist hospital, and Chinese medicine. The Drug retail segment includes chain drugstores and network distribution of pharmaceutical products. |
